AstraZeneca is going to be presenting the new data that is highlighting the breadth of the early oncology portfolio of the company at the annual meeting of AACR (American Association for cancer Research) in the region of New Orleans from 8to 13 April 2022.
The data from the 60 presentations including 3 mini-oral and 5 oral presentations is going to be featuring the next wave of the potential cancer medicines of the company spanning AstraZeneca’s immune-oncology (IO), Antibody Drug Conjugate (ADC), and DNA Damage Response (DDR) scientific platforms.
This new data is also including the main data that is shared from the potential three new medicines that are illustrating the innovative approach of the company for designing the molecules that is addressing the main challenges in the treatment of cancer including the ability for targeting the complementary and different mechanisms.
Susan Galbraith, executive vice president of Oncology R&D at AstraZeneca said that, they are serious about leading a revolution in the oncology, which has been why they are continuing to pioneer the new ways for the purpose of targeting cancer and also benefiting the patients with greater precision.
Susan Galbraith also said that, their data at the AACR from the upcoming wave of the immune-oncology medicines, and the antibody drug conjugates has been demonstrating the potential of their diverse portfolio and it has also been reflecting their vision for targeting cancer from every angle.
Writing is a medium to express feelings and convey facts. A creative mind never rests in peace and this amazing platform gives me the freedom to write about what I like most.
I’ve been a writer/blogger for the last twelve years and have covered technology-related topics. However, I also have considerable years of experience in writing for various domains – Technology, Beauty, Fashion, Pharmaceutical, human psychology etc. Technology is my forte.
I’ve handled many interesting projects. Writing is my passion. As an author, I’ve learned a lot in my long journey of penning down my thoughts!
After discussions with the government, Premier League clubs have agreed to stop sponsoring their front…
Analysts reported that Novatek, a Russian natural gas producer, acquired Shell's stake in the Sakhalin-2…
The electric drivetrain of the next generation for Volkswagen's "ID" has been unveiled. Family EV.…
According to research, global egg prices are expected to remain at an all-time high until…
Ohme becomes Audi's Official UK Smart Charger Partner Ohme has been selected as Audi's new…
GM Ventures has signed a strategic agreement to develop EnergyX's lithium extraction and refinery technology,…